VIE/FME (VIE/FME)

Vienna Stock Exchange: VIE/FME · EUR

€41.1

+0.51 (+1.3%)· Recorded snapshot

Market cap	11B
Revenue (ttm)	19.4B
Net income (ttm)	937.8M
EPS (ttm)	€3.34
P/E (trailing)	12.3x
P/E (forward)	10.2x
Dividend	€1.49 (3.62%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 19.4B
Net income (ttm): 937.8M
EPS (ttm): €3.34
P/E (trailing): 12.3x
P/E (forward): 10.2x
Market cap: 11B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E10.2

P25 n/aP50 n/aP75 n/a

Trailing P/E12.3

P25 n/aP50 n/aP75 n/a

ROE8.5

P25 n/aP50 n/aP75 n/a

ROIC6.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/FME indicators

Market & fundamental data

Available fields

237

Groups with data

Currency

EUR

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-03
Employees	107,226
Employees change	-3,163
Employees growth	-2.8%
Enterprise value	EUR 21.9B
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1996
Industry	Medical Care Facilities
Is primary listing	No
ISIN number	DE0005785802
Last earnings date	2026-08-04
Last refreshed	2026-10-30
Market cap	EUR 11B
Next earnings date	2026-11-03
Price	EUR 41.11
Price currency	EUR
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-29
Symbol	vie/FME
Website	https://www.freseniusmedicalcare.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	17.72x
Average P/E ratio (3Y)	18.9x
Average P/E ratio (5Y)	18.31x
Earnings yield	8.14%
EV/Earnings	23.33x
EV/EBIT	10.51x
EV/EBITDA	6.35x
EV/FCF	12.26x
EV/Sales	1.13x
FCF / EV yield	8.16%
FCF yield	16.24%
Forward P/E	10.23x
Graham number	63.20189
Graham upside	53.74%
Lynch fair value	EUR 17.54
Lynch upside	-57.34%
P/B ratio	0.81x
P/E ratio	12.29x
P/FCF ratio	6.16x
P/OCF ratio	3.88x
P/S ratio	0.57x
Price/EBITDA ratio	4.04x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	10.26%
EBITDA margin	14.01%
Effective tax rate	20.93%
FCF margin	9.19%
Gross margin	26.36%
Operating margin	10.26%
Pretax margin	7.73%
Profit margin	4.83%
Profit per employee	EUR 8,746
Profitable quarters	98
Profitable years	26
Revenue per employee	EUR 181,179
ROA	3.98%
ROA (5Y)	3.11%
ROCE	8.26%
ROE	8.52%
ROE (5Y)	6.59%
ROIC	6.64%
ROIC (5Y)	4.94%
Tax / revenue	1.62%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	49.98%
EPS growth (Q)	5.5%
EPS growth (QoQ)	89.7%
EPS growth 10Y	0.22%
EPS growth 3Y	18.11%
EPS growth 5Y	-0.38%
EPS growth quarters	1
EPS growth years	2
FCF growth	-12.85%
FCF growth (Q)	-0.1%
FCF growth (QoQ)	1,583.56%
FCF growth 3Y	1.24%
FCF growth 5Y	3.36%
Gross profit growth	6.34%
Gross profit growth (Q)	7.87%
Gross profit growth 3Y	2.03%
Gross profit growth 5Y	-0.41%
Net income growth	42.86%
Net income growth (Q)	-3.06%
Net income growth (QoQ)	85.81%
Net income growth 3Y	16.33%
Net income growth 5Y	-1.24%
Net income growth years	2
OCF growth	2.77%
OCF growth (Q)	11.02%
OCF growth (QoQ)	279.18%
OCF growth 10Y	4.73%
OCF growth 3Y	5.55%
OCF growth 5Y	2.86%
Operating income growth	26.09%
Operating income growth (Q)	32.77%
Operating income growth 3Y	9.03%
Operating income growth 5Y	-0.48%
Revenue growth	-0.47%
Revenue growth (Q)	1.44%
Revenue growth (QoQ)	5.39%
Revenue growth 10Y	2.06%
Revenue growth 3Y	-0.33%
Revenue growth 5Y	2.29%
Revenue growth quarters	1
Revenue growth years	1

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -1B
Depreciation and amortization	EUR 728.7M
EBIT	EUR 2B
EBITDA	EUR 2.7B
EPS	EUR 3.34
Financing cash flow	EUR -2.5B
Free cash flow	EUR 1.8B
Gross profit	EUR 5.1B
Income taxes	EUR 314.3M
Investing cash flow	EUR -912.5M
Net borrowing	EUR -481.9M
Net cash flow	EUR -658.9M
Net income	EUR 937.8M
Operating income	EUR 2B
Revenue	EUR 19.4B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	1.78
Book value per share	EUR 47.19
Debt / EBITDA	3.27
Debt / equity	0.81
Debt / FCF	6.15
Goodwill	EUR 14B
Interest coverage	5.2
Long-term assets	EUR 23.6B
Long-term liabilities	EUR 10.6B
Net cash (debt)	EUR -9.9B
Net cash / market cap	-90.23%
Net debt / EBITDA	3.64
Net debt / equity	0.73
Net debt / FCF	5.56
Piotroski F-Score	7
Property, plant and equipment	EUR 6.4B
Shareholders' equity	EUR 13.5B
Tangible book value	EUR -2.7B
Tangible book value per share	EUR -10.11
Total assets	EUR 31.3B
Total cash	EUR 1.1B
Total debt	EUR 11B
Total liabilities	EUR 17.8B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.62
Current assets	EUR 7.7B
Current liabilities	EUR 7.2B
Current ratio	1.07
Inventory turnover	6.61
Net working capital	EUR 1.8B
Quick ratio	0.63
Working capital	EUR 511.7M
Working capital turnover	13.01

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	4.44%
Dividend growth	3.47%
Dividend growth (3Y)	9.98%
Dividend growth (5Y)	-10.12%
Dividend growth years	2
Dividend payment date	2026-05-27
Dividend payment years	10
Dividend payout frequency	Annual
Dividend per share	EUR 1.49
Dividend yield	3.62%
Ex-dividend date	2026-05-22
Last dividend	EUR 1.49
Payout ratio	42.67%
Shareholder yield	8.06%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 39.80
1D price change	1.26%
1M price change	1.73%
1M total return	1.73%
1W price change	6.42%
1W total return	6.42%
1Y price change	-11.57%
1Y return CAGR	-8.05%
1Y total return	-8.05%
20-day SMA	EUR 39.27
200-day SMA	EUR 39.63
3M price change	-4.84%
3M total return	-4.84%
3Y price change	31.64%
3Y return CAGR	13.15%
3Y total return	44.86%
50-day SMA	EUR 39.42
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 47.04
52-week high date	2025-10-29
52-week low	EUR 34.69
52-week low date	2026-05-05
5Y price change	-30.93%
5Y return CAGR	-4.39%
5Y total return	-20.1%
6M price change	5.93%
6M total return	10.15%
All-time high	EUR 93.02
All-time high date	2018-01-31
All-time low	EUR 26.37
All-time low date	2022-10-31
Average true range (ATR)	EUR 0.72
Average volume	0
Change from 52-week high	-12.61%
Change from 52-week low	18.51%
Change from all-time high	-55.81%
Change from all-time low	55.9%
Change from open	0.88%
Day's gap	0.37%
High price	EUR 41.11
Low price	EUR 40.75
Monthly RSI	49.58
Open price	EUR 40.75
Position in 52-week range	100%
Previous close	EUR 40.60
Price vs 150-day SMA	3.3%
Price vs 20-day SMA	4.7%
Price vs 200-day SMA	3.73%
Price vs 50-day SMA	4.28%
Relative volume	1.1
RSI	60.06
Sharpe ratio	-0.24
Sharpe ratio (3Y)	0.39
Sharpe ratio (5Y)	-0.09
Sortino ratio	-0.14
Sortino ratio (3Y)	0.7
Sortino ratio (5Y)	0.05
Weekly RSI	54.61
YTD price change	1.43%
YTD total return	5.47%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	197.8M
Shares change (QoQ)	-2.47%
Shares change (YoY)	-4.44%
Shares held by insiders	0.04%
Shares held by institutions	48.44%

Deeper analysis on VIE/FME

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/FME report

Is a complete VIE/FME research report available?

No complete published report is available for vie/FME (VIE/FME) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/FME (VIE/FME)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/FME

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/FME indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/FME

Frequently asked questions